USA TODAY: What happens to drug companies that commit federal crimes? For the nation’s No. 1 drug company, the answer is: some pain, more gain.
FDA Revisits Issue Of Antidepressants for Youths New Analysis May Pressure Agency to Set Limit on Use Because of Suicide Risk
By ANNA WILDE MATHEWS THE WALL STREET JOURNAL EXCERPT: A new Food and Drug Administration analysis of clinical-trial data shows evidence of a link between
Lilly Plans Broad Access To Results of Drug Trials
By LEILA ABBOUD THE WALL STREET JOURNAL Seeking to defuse criticism that pharmaceutical companies hush up negative results in clinical trials, U.S. drug maker Eli
